Azetidine-substituted fluorescent compounds

US9933417B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9933417-B2
Application numberUS-201515301270-A
CountryUS
Kind codeB2
Filing dateApr 1, 2015
Priority dateApr 1, 2014
Publication dateApr 3, 2018
Grant dateApr 3, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The presently-disclosed subject matter includes azetidine-substituted fluorescent compounds, where the compounds may be used as probes, dyes, tags, and the like. The presently-disclosed subject matter also includes kits comprising the same as well as methods for using the same to detect a target substance.

First claim

Opening claim text (preview).

What is claimed is: 1. A compound of the formula: wherein: each R is independently selected from halogen, H, CN, OH, O(alkyl), O(aryl), SH, S(alkyl), S(aryl), amine, NO 2 , CHO, COOH, C(O)NR 2 , COO(alkyl), COO(aryl), PO 3 H 2 , SO 3 H, and alkyl, alkyl being optionally substituted with halogen, ═O, OH, O(alkyl), O(aryl), SH, S(alkyl), S(aryl), NH 2 , NHR, NR 2 , NO 2 , CHO, COO, COOH, C(O)NR 2 , COO(alkyl), COO(aryl), PO 3 H 2 , and/or SO 3 H; Q is selected from CR 2 , NR, O, SiR (2) , and Se; W is selected from C and N; X is selected from a lone pair of electrons, H, alkyl, aryl, halogen, CN, OH, O(alkyl), O(aryl), SH, S(alkyl), S(aryl), amine, NO 2 , CHO, COOH, C(O)NR 2 , COO(alkyl), COO(aryl), PO 3 H 2 , and SO 3 H, X being optionally substituted with halogen, ═O, OH, O(alkyl), O(aryl), SH, S(alkyl), S(aryl), NH 2 , NHR, NR 2 , NO 2 , CHO, COO, COOH, C(O)NR 2 , COO(alkyl), COO(aryl), C(O)NR 2 , PO 3 H 2 , and/or SO 3 H; Y is selected from H, CR (2) , C(O)NR 2 , NR, O, and S; and Z is selected from H, halogen, CN, OH, O(alkyl), O(aryl), SH, S(alkyl), S(aryl), amine, NO 2 , CHO, COOH, C(O)NR 2 , COO(alkyl), COO(aryl), PO 3 H 2 , SO 3 H, aryl, and alkyl, alkyl and aryl being optionally substituted with halogen, ═O, OH, O(alkyl), O(aryl), SH, S(alkyl), S(aryl), NH 2 , NHR, NR 2 , NO 2 , CHO, COOH, C(O)NR 2 , COO(alkyl), COO(aryl), PO 3 H 2 , and SO 3 H, or wherein Z and Y, taken together with the atoms to which they are bonded, can form a substituted or unsubstituted 5-7 membered ring. 2. The compound of claim 1 , wherein amine is independently selected from NH 2 , NH(alkyl), NH(aryl), N(alkyl) 2 , and N(aryl) 2 . 3. The compound of claim 1 , wherein Y and Z, taken together with the atoms to which they are bonded, form the 5-7 membered ring substituted with one or more substituents selected from halogen, CN, ═O, OH, O(alkyl), O(aryl), SH, S(alkyl), S(aryl), NH 2 , NHR, NR 2 , NO 2 , CHO, COOH, C(O)NR 2 , COO(alkyl), COO(aryl), PO 3 H 2 , SO 3 H, and alkyl. 4. The compound of claim 3 , wherein Y and Z, taken together with the atoms to which they are bonded, form the 5-7 membered ring substituted with an unsubstituted or substituted azetidine group. 5. The compound of claim 1 , according to the following formula: wherein R′ is selected from halogen, H, CN, OH, O(alkyl), O(aryl), SH, S(alkyl), S(aryl), amine, NO 2 , CHO, COOH, C(O)NR 2 , COO(alkyl), COO(aryl), PO 3 H 2 , SO 3 H, and alkyl, alkyl being optionally substituted with halogen, ═O, OH, O(alkyl), O(aryl), SH, S(alkyl), S(aryl), NH 2 , NHR, NR 2 , NO 2 , CHO, COO, COOH, COO(alkyl), COO(aryl), PO 3 H 2 , and/or SO 3 H. 6. The compound of claim 1 , according to the following formula: wherein R′ is selected from an azetidine group that is unsubstituted or substituted with one or more of halogen, H, CN, OH, O(alkyl), O(aryl), SH, S(alkyl), S(aryl), amine, NO 2 , CHO, COOH, C(O)NR 2 , COO(alkyl), COO(aryl), PO 3 H 2 , SO 3 H, and alkyl. 7. The compound of claim 1 , according to the following formula: 8. The compound of claim 1 , according to the following formula: 9. The compound of claim 1 , according to the following formula: 10. The compound of claim 1 , according to the following formula: 11. The compound of claim 1 , according to the following formula: 12. The compound of claim 1 , according to the following formula: 13. The compound of claim 1 , according to the following formula: 14. The compound of claim 1 , according to the following formula: 15. The compound of claim 1 , wherein X is a substituted aryl. 16. The compound of claim 1 , wherein X is selected from: 17. The compound of claim 1 , wherein X is selected from H and a lone pair of electrons. 18. A compound according to a formula selected from: 19. A method for detecting a target substance, comprising: contacting a sample with a compound of the formula: wherein: each R is independently selected from halogen, H, CN, OH, O(alkyl), O(aryl), SH, S(alkyl), S(aryl), amine, NO 2 , CHO, COOH, C(O)NR 2 , COO(alkyl), COO(aryl), PO 3 H 2 , SO 3 H, and alkyl, alkyl being optionally substituted with halogen, ═O, OH, O(alkyl), O(aryl), SH, S(alkyl), S(aryl), NH 2 , NHR, NR 2 , NO 2 , CHO, COO, COOH, C(O)NR 2 , COO(alkyl), COO(aryl), PO 3 H 2 , and/or SO 3 H; Q is selected from CR (2) , NR, O, S, SiR (2) , and Se; W is selected from C and N; X is selected from a lone pair of electrons, H, alkyl, aryl, halogen, CN, OH, O(alkyl), O(aryl), SH, S(alkyl), S(aryl), amine, NO 2 , CHO, COOH, C(O)NR 2 , COO(alkyl), COO(aryl), PO 3 H 2 , and SO 3 H, X being optionally substituted with halogen, ═O, OH, O(alkyl), O(aryl), SH, S(alkyl), S(aryl), NH 2 , NHR, NR 2 , NO 2 , CHO, COO, COOH, C(O)NR 2 , COO(alkyl), COO(aryl), PO 3 H 2 , and/or SO 3 H; Y is selected from H, CR (2) , C(O)NR 2 , NR, O, and S; and Z is selected from H, halogen, CN, OH, O(alkyl), O(aryl), SH, S(alkyl), S(aryl), amine, NO 2 , CHO, COOH, C(O)NR 2 , COO(alkyl), COO(aryl), PO 3 H 2 , SO 3 H, aryl, and alkyl, alkyl and aryl being optionally substituted with halogen, ═O, OH, O(alkyl), O(aryl), SH, S(alkyl), S(aryl), NH 2 , NHR, NR 2 , NO 2 , CHO, COOH, C(O)NR 2 , COO(alkyl), COO(aryl), PO 3 H 2 , and SO 3 H, or wherein Z and Y, taken together with the atoms to which they are bonded, can form a substituted or unsubstituted 5-7 membered ring; and detecting an emission light from the compound, the emission light indicating the presence of the target substance. 20. The method of c

Assignees

Inventors

Classifications

  • Pyronines {; Xanthon, thioxanthon, selenoxanthan, telluroxanthon dyes} · CPC title

  • Coumarine dyes · CPC title

  • one oxygen and one nitrogen atom, e.g. guanine · CPC title

  • directly linked by a ring-member-to-ring-member bond · CPC title

  • Spiro-condensed systems · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9933417B2 cover?
The presently-disclosed subject matter includes azetidine-substituted fluorescent compounds, where the compounds may be used as probes, dyes, tags, and the like. The presently-disclosed subject matter also includes kits comprising the same as well as methods for using the same to detect a target substance.
Who is the assignee on this patent?
Hughes Howard Med Inst
What technology area does this patent fall under?
Primary CPC classification G01N33/52. Mapped technology areas include Physics.
When was this patent published?
Publication date Tue Apr 03 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).